U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 68

1.
Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36.
L A Cannon-Albright, D E Goldgar, E C Wright, A Turco, M Jost, L J Meyer, M Piepkorn, J J Zone, M H Skolnick
Am J Hum Genet. 1990 May; 46(5): 912–918.
PMCID:
PMC1683591
SummaryPage BrowsePDF–948K
2.
Complementation of the xeroderma pigmentosum DNA repair synthesis defect with Escherichia coli UvrABC proteins in a cell-free system.
J Hansson, L Grossman, T Lindahl, R D Wood
Nucleic Acids Res. 1990 Jan 11; 18(1): 35–40. doi: 10.1093/nar/18.1.35
PMCID:
PMC330200
SummaryPage BrowsePDF–1.5M
3.
Fibroblasts from patients with hereditary cutaneous malignant melanoma are abnormally sensitive to the mutagenic effect of simulated sunlight and 4-nitroquinoline 1-oxide.
J N Howell, M H Greene, R C Corner, V M Maher, J J McCormick
Proc Natl Acad Sci U S A. 1984 Feb; 81(4): 1179–1183. doi: 10.1073/pnas.81.4.1179
PMCID:
PMC344789
SummaryPage BrowsePDF–1.0M
4.
Familial cutaneous malignant melanoma: autosomal dominant trait possibly linked to the Rh locus.
M H Greene, L R Goldin, W H Clark, Jr, E Lovrien, K H Kraemer, M A Tucker, D E Elder, M C Fraser, S Rowe
Proc Natl Acad Sci U S A. 1983 Oct; 80(19): 6071–6075. doi: 10.1073/pnas.80.19.6071
PMCID:
PMC534362
SummaryPage BrowsePDF–1.0M
5.
Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation
Pedram Gerami, Oriol Yélamos, Christina Y. Lee, Roxana Obregon, Pedram Yazdan, Lauren M. Sholl, Gerta E. Guitart, Ching-Ni Njauw, Hensin Tsao
JAMA Dermatol. Author manuscript; available in PMC 2018 Mar 1.
Published in final edited form as: JAMA Dermatol. 2015 Nov; 151(11): 1235–1239. doi: 10.1001/jamadermatol.2015.1701
PMCID:
PMC5831190
AbstractArticlePDF–686K
6.
Correlation of clinical pigmentary characteristics with histopathologically-confirmed dysplastic nevi in nonfamilial melanoma patients. Studies of melanocytic nevi IX.
G. C. Roush, R. L. Barnhill
Br J Cancer. 1991 Nov; 64(5): 943–947. doi: 10.1038/bjc.1991.431
PMCID:
PMC1977446
SummaryPage BrowsePDF–950K
7.
Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
A. M. Goldstein, L. R. Goldin, N. C. Dracopoli, W. H. Clark, Jr, M. A. Tucker
Am J Hum Genet. 1996 May; 58(5): 1050–1056.
PMCID:
PMC1914626
SummaryPage BrowsePDF–1.0M
8.
The dysplastic nevus: from historical perspective to management in the modern era: II. Molecular aspects and clinical management
Keith Duffy, Douglas Grossman
J Am Acad Dermatol. Author manuscript; available in PMC 2013 Jul 1.
Published in final edited form as: J Am Acad Dermatol. 2012 Jul; 67(1): 19.e1–32. doi: 10.1016/j.jaad.2012.03.013
PMCID:
PMC3621132
AbstractArticlePDF–314K
9.
On the Interplay of Telomeres, Nevi and the Risk of Melanoma
Clara Bodelon, Ruth M. Pfeiffer, Valentina Bollati, Julien Debbache, Donato Calista, Paola Ghiorzo, Maria Concetta Fargnoli, Giovanna Bianchi-Scarra, Ketty Peris, Mirjam Hoxha, Amy Hutchinson, Laurie Burdette, Laura Burke, Shenying Fang, Margaret A. Tucker, Alisa M. Goldstein, Jeffrey E. Lee, Qingyi Wei, Sharon A. Savage, Xiaohong R. Yang, Christopher Amos, Maria Teresa Landi
PLoS One. 2012; 7(12): e52466. Published online 2012 Dec 27. doi: 10.1371/journal.pone.0052466
PMCID:
PMC3531488
AbstractArticlePDF–116K
10.
Standardized Computer-Assisted Analysis of 5-hmC Immunoreactivity in Dysplastic Nevi and Superficial Spreading Melanomas
Elias A. T. Koch, Carola Berking, Ramona Erber, Michael Erdmann, Franklin Kiesewetter, Stefan Schliep, Markus V. Heppt
Int J Mol Sci. 2023 Oct; 24(19): 14711. Published online 2023 Sep 28. doi: 10.3390/ijms241914711
PMCID:
PMC10572721
AbstractArticlePDF–11M
11.
Higher Expression of the Heterogeneous Nuclear Ribonucleoprotein K in Melanoma
Fushi Wen, Alex Shen, Reneé Shanas, Achyut Bhattacharyya, Fangru Lian, Galen Hostetter, Jiaqi Shi
Ann Surg Oncol. Author manuscript; available in PMC 2011 Oct 1.
Published in final edited form as: Ann Surg Oncol. 2010 Oct; 17(10): 2619–2627. Published online 2010 May 25. doi: 10.1245/s10434-010-1121-1
PMCID:
PMC2943057
AbstractArticlePDF–708K
12.
BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi
L.P. Nguyen, A. Emley, N. Wajapeyee, M.R. Green, M. Mahalingam
Br J Dermatol. Author manuscript; available in PMC 2010 Sep 1.
Published in final edited form as: Br J Dermatol. 2010 Mar; 162(3): 677–680. Published online 2009 Nov 16. doi: 10.1111/j.1365-2133.2009.09558.x
PMCID:
PMC2921125
AbstractArticlePDF–1.6M
13.
Cyclin D1 and D3 expression in melanocytic skin lesions
Ana Alekseenko, Anna Wojas-Pelc, Grzegorz J. Lis, Alicja Furgał-Borzych, Grzegorz Surówka, Jan A. Litwin
Arch Dermatol Res. 2010; 302(7): 545–550. Published online 2010 May 23. doi: 10.1007/s00403-010-1054-3
PMCID:
PMC2913004
AbstractArticlePDF–467K
14.
Undifferentiated Carcinoma with Osteoclastic Giant Cells (UCOCGC) of the pancreas associated with the Familial Atypical Multiple Mole Melanoma syndrome (FAMMM)
Jan-Bart M Koorstra, Anirban Maitra, Folkert HM Morsink, Paul Drillenburg, Fiebo JW ten Kate, Ralph H Hruban, G Johan A Offerhaus
Am J Surg Pathol. Author manuscript; available in PMC 2009 Dec 1.
Published in final edited form as: Am J Surg Pathol. 2008 Dec; 32(12): 1905–1909. doi: 10.1097/PAS.0b013e31818371cd
PMCID:
PMC2704013
AbstractArticlePDF–2.9M
15.
Malignant melanoma in a black child: predisposing precursors and management.
Olanrewaju T. Adedoyin, Abdul-Wahab B. R. Johnson, Ayodele I. Ojuawo, Enoch A. O. Afolayan, Kayode A. Adeniji
J Natl Med Assoc. 2004 Oct; 96(10): 1368–1373.
PMCID:
PMC2568537
SummaryPage BrowsePDF–1.4M
16.
Harvey-ras oncogene restriction fragment alleles in familial melanoma kindreds.
C. Sutherland, H. M. Shaw, C. Roberts, J. Grace, M. M. Stewart, W. H. McCarthy, R. F. Kefford
Br J Cancer. 1986 Nov; 54(5): 787–790. doi: 10.1038/bjc.1986.241
PMCID:
PMC2001542
SummaryPage BrowsePDF–735K
17.
Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
A. M. Goldstein, N. C. Dracopoli, M. Engelstein, M. C. Fraser, W. H. Clark, Jr, M. A. Tucker
Am J Hum Genet. 1994 Mar; 54(3): 489–496.
PMCID:
PMC1918143
SummaryPage BrowsePDF–1.0M
18.
FISH as an effective diagnostic tool for the management of challenging melanocytic lesions
Mathew W Moore, Robert Gasparini
Diagn Pathol. 2011; 6: 76. Published online 2011 Aug 11. doi: 10.1186/1746-1596-6-76
PMCID:
PMC3162533
AbstractArticlePDF–200K
19.
Molecular Aspects of Melanocytic Dysplastic Nevi
Mahmoud Rezk Abd-Elwahed Hussein, Gary Stewart Wood
J Mol Diagn. 2002 May; 4(2): 71–80. doi: 10.1016/S1525-1578(10)60684-8
PMCID:
PMC1906986
AbstractArticlePDF–542K
20.
Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression.
T. J. de Vries, P. H. Quax, M. Denijn, K. N. Verrijp, J. H. Verheijen, H. W. Verspaget, U. H. Weidle, D. J. Ruiter, G. N. van Muijen
Am J Pathol. 1994 Jan; 144(1): 70–81.
PMCID:
PMC1887106
SummaryPage BrowsePDF–4.8M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center